摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,1'S)-4-<1'-(4''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane | 151774-96-8

中文名称
——
中文别名
——
英文名称
(4R,1'S)-4-<1'-(4''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane
英文别名
(4R)-4-[(1S)-1-(4-bromophenyl)ethyl]-2,2-dimethyl-1,3-dioxolane
(4R,1'S)-4-<1'-(4''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane化学式
CAS
151774-96-8
化学式
C13H17BrO2
mdl
——
分子量
285.181
InChiKey
DFDPLBFPMIAMAM-CABZTGNLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    (4R,1'S)-4-<1'-(4''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane 在 palladium on activated charcoal 盐酸氢气叔丁基锂 作用下, 以 甲醇二氯甲烷 为溶剂, 生成 (2R,3S)-3-<4'-(2''-methylpropyl)phenyl>butane-1,2-diol
    参考文献:
    名称:
    对映选择性合成2-芳基丙酸非甾体抗炎药及相关化合物。
    摘要:
    (S)-2- [4'-(2″-甲基丙基)苯基丙酸(布洛芬)和(S)-2-(3'-苯甲酰基苯基)丙酸(酮洛芬)已经以高对映体过量的方式合成。立体化学的控制是通过Sharpless环氧化作用结合,然后对引入的苄基环氧化物氧键进行催化氢解来实现的。另外,通过以上方法制备的在钯存在下的有机化合物与对映纯的2-(3-碘苯基)丙酸和2-(4-碘苯基)丙酸的偶联是合成光学活性芳基丙酸的一般方法。酸。
    DOI:
    10.1016/0040-4020(95)00805-i
  • 作为产物:
    描述:
    (2S,3S)-3-methyl-3-<4'-(trimethylsilyl)phenyl>oxiranemethanol 在 palladium on activated charcoal sodium hydroxideN-氯代丁二酰亚胺氢气对甲苯磺酸 、 lithium bromide 作用下, 以 甲醇 为溶剂, 反应 12.75h, 生成 (4R,1'S)-4-<1'-(4''-bromophenyl)ethyl>-2,2-dimethyl-1,3-dioxolane
    参考文献:
    名称:
    对映选择性合成2-芳基丙酸非甾体抗炎药及相关化合物。
    摘要:
    (S)-2- [4'-(2″-甲基丙基)苯基丙酸(布洛芬)和(S)-2-(3'-苯甲酰基苯基)丙酸(酮洛芬)已经以高对映体过量的方式合成。立体化学的控制是通过Sharpless环氧化作用结合,然后对引入的苄基环氧化物氧键进行催化氢解来实现的。另外,通过以上方法制备的在钯存在下的有机化合物与对映纯的2-(3-碘苯基)丙酸和2-(4-碘苯基)丙酸的偶联是合成光学活性芳基丙酸的一般方法。酸。
    DOI:
    10.1016/0040-4020(95)00805-i
点击查看最新优质反应信息

文献信息

  • Enantioselective synthesis of the four isomers of the biologically active metabolite of the 2-arylpropanoic acid NSAID, ximoprofen, and assessment of their inhibitory activity on human platelet cyclo-oxygenase in vitro
    作者:David P.G. Hamon、Peter J. Hayball、Ralph A. Massy-Westropp、Josephine L. Newton、Julie G. Tamblyn
    DOI:10.1016/0957-4166(95)00443-2
    日期:1996.1
    The four stereoisomers of the parent keto acid of the oximino drug ximoprofen have been prepared in high enantiomeric purity. The stereochemistry in the propionic acid chain was established by the combination of Sharpless epoxidation followed by stereoselective hydrogenolysis of the benzylic carbon-oxygen bond with inversion of configuration. The stereochemistry of the centre in the cyclohexanone ring was controlled by the stereoselective conjugate addition of the arylpropanoic acid moiety to the enantiomers of 5-(trimethylsilyl)-2-cyclohexenone with subsequent removal of the trimethylsilyl group. The pharmacological activity of each of the four isomers of the keto acid parent of ximoprofen were assessed by their in vitro inhibition of human platelet cyclo-oxygenase. As expected, the (S) configuration of the propionic acid chain was essential for activity but it was also found that the stereochemistry in the cyclohexanone moiety was important. Attempts to separate the (E) and (Z) isomers of the oxime derivative from one of the stereoisomers were unsuccessful.
  • Concerning the enantioselective synthesis of the isomers of the arylpropanoic acid NSAID ximoprofen
    作者:David P.G. Hamon、Ralph A. Massy-Westropp、Josephine L. Newton
    DOI:10.1016/s0040-4039(00)79970-9
    日期:1994.2
    All four stereoisomers of the parent ketone of the oximido drug ximoprofen have been prepared pure. An attempt to isolate the pure E and Z isomers of the oxime derivative from one of these stereoisomers was unsuccessful.
  • Asymmetric synthesis of ibuprofen and ketoprofen
    作者:David P.G. Hamon、Ralph A. Massy-Westropp、Josephine L. Newton
    DOI:10.1016/s0957-4166(00)80334-1
    日期:1993.7
    (S)-2-[4'-(2''-Methylpropyl)phenyl]propanoic acid (ibuprofen) and (S)-2-(3'-benzoylphenyl)propanoic acid (ketoprofen) have been synthesis in high enantiomeric excess. Control of the stereochemistry was achieved by a combination of Sharpless epoxidation followed by catalytic hydrogenolysis of the introduced benzylic epoxide oxygen bond.
  • Enantioselective syntheses of 2-arylpropanoic acid non-steroidal antiinflammatory drugs and related compounds.
    作者:David P.G. Hamon、Ralph A. Massy-Westropp、Josephine L. Newton
    DOI:10.1016/0040-4020(95)00805-i
    日期:1995.11
    Control of stereochemistry was achieved by a combination of Sharpless epoxidalion followed by catalytic hydrogenolysis of the introduced benzylic epoxide oxygen bond. Also, the coupling of organic compounds in the presence of palladium with enantiopure 2-(3-iodophenyl)propanoic and 2-(4-iodophenyl)propanoic acids, prepared by the methodology above, is a general method for the synthesis of optically active
    (S)-2- [4'-(2″-甲基丙基)苯基丙酸(布洛芬)和(S)-2-(3'-苯甲酰基苯基)丙酸(酮洛芬)已经以高对映体过量的方式合成。立体化学的控制是通过Sharpless环氧化作用结合,然后对引入的苄基环氧化物氧键进行催化氢解来实现的。另外,通过以上方法制备的在钯存在下的有机化合物与对映纯的2-(3-碘苯基)丙酸和2-(4-碘苯基)丙酸的偶联是合成光学活性芳基丙酸的一般方法。酸。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐